Abstract
Larvae of the insect Galleria mellonella are increasingly being used for studying pathogenic microbes and their virulence mechanisms, and as a rapid model for screening novel antimicrobial agents. The larvae (waxworms) are most frequently infected by injection of pathogenic organisms into the haemocoel through the insect’s prolegs. The mostly widely used method for restraining the waxworms for injection is by grasping them between the operator’s fingers, which puts the operator at risk of needle stick injury, an important consideration when working with highly pathogenic and/or drug-resistant microorganisms. While use of a stab proof glove can reduce this risk of injury, it does so at the loss of manual dexterity and speed, resulting in a more labour-intensive and cumbersome assay. We describe a simple cost effective device (the so-called ‘Galleria Grabber’) for restraining waxworms for injection that keeps the operator’s fingers clear of the needle thus reducing the risk of injury.
Introduction
Larvae (waxworms) of the Greater wax moth Galleria melonella have become a widely used surrogate host for studying pathogenic microbes. In recent years, they have been used for studying virulence mechanisms, investigating differences between clinical isolates as well as for preliminary investigation of the efficacy of antimicrobial compounds, for a wide range of both Gram-positive and Gram-negative bacteria1–12, fungi13–19 and viruses20–22. The use of waxworms as a model host has many advantages. The waxworms themselves are cheap and easy to obtain from commercial insect suppliers, and can be housed in large numbers to allow for greater study sizes at low cost. Waxworms possess an innate immune system that contains many analogous functions to that seen in humans, including phagocytosis and the production of antimicrobial peptides and reactive oxygen and nitrogen species23. Unlike other non-mammalian model organisms, such as Caenorhabditis elegans, Danio rerio and Drosophila melanogaster24–21, waxworms can be incubated at 37°C which allows for the study of clinically relevant human pathogens at a temperature that mimics the human host. Finally, as insects, G. mellonella are not currently subject to the same ethical restrictions that small mammalian models are, meaning there is a low barrier to entry for researchers wishing to move their studies into a model host.
Infection of waxworms is typically carried out on 5th instar insects, when the waxworms are at their largest, typically around 2cm in length and 100mg in weight. The most common method of infection is by injection into the haemocoel through the last proleg of the insect; methods for injection vary between laboratories. One method is to immobilize the needle itself and then place the waxworm onto the needle for injection. Another more favoured method is to immobilise the waxworms between the operator’s fingers28 and place the needle into the insect’s proleg, lifting the needle away from the operator with the insect attached before pushing the plunger on the syringe. Both of these injection techniques present a hazard to the researcher and can result in needle stick injury and possible infection.
A recent article highlighted the use of a stab-proof glove to reduce the chance of this type of injury, while immobilising the waxworms over a pipette tip fixed to some paper29. We have tried this technique, and found that it reduced the efficiency of injection, from 3-4 infections per minute to 1 infection per minute, resulting in a lower injection rate and a more labour-intensive assay. Because of this, we investigated the possibility of using a simple restraining device to hold waxworms in place for injection, in a way that removes the operator’s hand from the vicinity of the needle, allowing for maximum mobility and safety of the operator.
Materials and methods
Preparation of bacteria
The Staphylococcus aureus isolate XEN3630 (Perkin Elmer) was grown overnight with shaking at 200rpm in Tryptic Soy broth (Oxoid) at 37°C. Cells were washed twice in phosphate buffered saline (PBS) (Sigma-Aldrich) and then resuspended in PBS to an optical density at 600nm (OD600) of 1, equivalent to approx. 5×109 CFU ml−1. Resuspended cultures were serially diluted and plated onto Tryptic Soy agar (Oxoid) to retrospectively determine the bacterial counts used for injection. Inoculation doses were drawn into 1 ml ultra-fine (29 gauge) needle insulin syringes (BD, Wellington) for injection into the waxworms. Groups of waxworms were injected with 20 μl of either approx. 5×107 CFU ml−1, 5×108 CFU ml−1 or 5×109 CFU ml−1 S. aureus XEN36.
Selection, infection and monitoring of G. mellonella waxworms
5th instar waxworms were selected based on consistency in size and split into eight groups of 12.Four groups were injected with either PBS or doses of 105−107 CFU S. aureus XEN36 using the most common technique of grasping the waxworms between the operator’s thumb and index finger and injecting into the waxworm’s last proleg. The remaining four groups were injected with either PBS or doses of 105−107 CFU S. aureus XEN36 using the newly described restraining device (which we have dubbed the ’Galleria Grabber’), which comprises a 12 cm × 9 cm kitchen sponge and a large bulldog clip (approx. 50 cm) (Fig. 1A). To comfortably restrain the waxworms, the sponge was folded in half and secured using the bulldog clip (Fig. 1B). The open ends of the folded sponge were peeled back and held in place (Fig. 1C). Next, a waxworm was placed within the sponge and held in place while the open end of the sponge was released (Fig. 1D). Once the waxworm was securely held in place, the insulin syringe was inserted into the haemocoel via the insect’s last proleg (Fig. 1E). Once the needle was in place the waxworm was released from the restraining device (Fig. 1F). If the needle is correctly placed, the waxworm remains attached to the needle of the syringe. Once the needle had been securely inserted into the waxworm, the insect was removed from the restraining device and the plunger of the syringe pushed down to inject the desired inoculum.
Once injected, waxworms were housed in individual wells of 24 well tissue culture dishes (Nunc) with the lids taped down to ensure against escape. These dishes were placed inside a secondary container to ensure containment. Waxworm mortality was monitored over 5 days.
Results and discussion
We observed no differences in the infection dynamics between the groups of waxworms injected with S. aureus XEN36 after restraint using the novel ‘Galleria Grabber’ device described compared to restraint by holding the waxworms between the operator’s thumb and index finger. For both restraint techniques, we observed no mortality from the waxworms injected with PBS (Fig. 2). In contrast, the majority of waxworms injected with approx. 107 CFU S. aureus XEN36 died within 24 hours (Fig. 2). We observed a dose dependent mortality for waxworms injected with S. aureus XEN36, with 66% of waxworms injected with approx. 106 CFU succumbing to infection (Fig. 2). No mortality was seen after injection with 105 CFU S. aureus XEN36 (Fig. 2).
The ‘Galleria Grabber’ allows for easy injection of a large number of waxworms (approx. 3 per minute), while greatly reducing the opportunity for the operator to suffer a needle stick injury. With the increasing popularity of waxworms as a model host for studies involving dangerous human pathogens12, including clinical and/or drug-resistant isolates, protecting researchers from accidental laboratory infection is of great importance. While the use of a stab-resistant glove addresses this issue, it does compromise the speed at which waxworms can be injected. With this new restraint method we were also able to inject smaller waxworms with ease. Most importantly, the new methodology described removes the operator’s hand from the vicinity of needles loaded with pathogenic/drug-resistant microbes, allowing for maximum mobility and safety of the operator without compromising the speed of the assay.
Funding
This work was supported by internal University of Auckland funds.
Disclosure of interest
The authors report no conflicts of interest.
Footnotes
Mailing address: Dept. Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, New Zealand.